drug

blinatumomab

1 story · latest Aug 4, 2026

Status: FDA approved Dec 2014 · BLA125557
Brand: Blincyto
Trials: 4 registered trials in coverage

Relationships

Developed by Amgen

Timeline

Amgen updates MariTide pipeline, discontinues AMG 513, keeps pressing FDA on TAVNEOS

Aug 4Quarterly updateAMG-513 Amgen

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.